US Pharma MarketingThe post Addressing access and equity in sickle cell disease care appeared first on Clinical Trials Arena.
Addressing access and equity in sickle cell disease care
According to GlobalData, the burden of sickle cell disease was estimated at approximately 400,000 diagnosed prevalent cases in 2025. According to GlobalData, the burden of sickle cell disease was estimated at approximately 400,000 diagnosed prevalent cases in 2025. SCD is inherited when someone gets two copies of a gene that codes for an abnormal haemoglobin. Credit: 3dMediSphere via Shutterstock.com. Sickle cell disease (SCD) is a genetic blood disorder that causes red blood cells to form in a crescent moon shape. These sickled blood cells can stick together and prevent oxygen from getting to a person’s tissues and organs. SCD is…
According to GlobalData, the burden of sickle cell disease was estimated at approximately 400,000 diagnosed prevalent cases in 2025.
Source: Clinical Trials Arena